参考文献/References:
[1] Sheldon RS, Grubb BP II, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope[J]. Heart Rhythm,2015,12:e41-63.
[2] Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope[J]. N Engl J Med,2002,347:878-885.
[3] Del Rosso A, Alboni P, Brignole M, et al. Relation of clinical presentation of syncope to the age of patients[J]. Am J Cardiol,2005,96:1431-1435.
[4]Arthur W, Kaye GC. The pathophysiology of common causes of syncope[J]. Postgrad Med J, 2000,76(902):750-753.
[5] Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope(version 2009)[J]. Eur Heart J,2009,30(21):2631-2671.
[6]Alboni P,Alboni M.Typical vasovagal syncope as a ‘‘defense mechanism’’ for the heart by contrasting sympathetic overactivity[J]. Clin Auton Res,2017,27:253-261.
[7]Alboni P, Bondanelli M, Dinelli M, et al.Role of the serotoninergic system in the genesis of vasovagal syncope[J]. Europace,2000,2:172-180.
[8] Grubb BP. Dysautonomic (orthostatic) syncope. In: Grubb BP, Olshansky B (eds) Syncope: mechanisms and management[M]. Futura, Armonk, 1998.73-106.
[9]Jardine DL, Melton IC, Crozier JG, et al.Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope[J]. Am J Physiol Heart Circ Physiol,2002,282(5):H1804-H1809.
[10]White CM, Tsikouris JP. A review of pathophysiology and therapy of patients with vasovagal syncope[J]. Pharmacotherapy,2000,20:158-165.
[11] Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope[J]. Eur J Card Pacing Electrophysiol,1992,3:180-183.
[12] Brignole M,Menozzi C,del Rosso A,et al. New classification of haemodynamics of vasovagal syncope:beyond the VASIS classification[J]. Europace,2000,2:66-76.
[13]Writing Committee Members,Shen WK,Sheldon RS,et al. 2017 ACC/ AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J].Heart Rhythm,2017,14 (8):e155-217.
[14]Chandiramani S,?Cohorn LC,?Chandiramani S.Heart rate changes during acute mental stress with closed loop stimulation: report on two single-blinded, pacemaker studies[J]. PACE,2007,30:976-984.
[15]Res JCJ, van Woersem RJ, Malinowski K,et al. Dual-chamber pacing and closed- loop regulation clinical results[J]. Prog Biomed Res,1997,3:118-121.
[16]Chandiramani S, Cohorn LC, Chandiramani S. Heart rate changes during acute mental stress with closed loop stimulation:report on two single-blinded, pace-makers studies[J]. Pacing Clin Electrophysiol,2007,30:976-984.
[17]Coenen M,Malinowski K,Spitzer W,et al. Closed loop stimulation and accelerometer-based rate adaptation:results of the PROVIDE study[J]. Europace,2008,10:327-333.
[18]Ruzieh M,Grubb BP.Vasovagal syncope—role of closed loop stimulation pacing[J].Trends Cardiovasc Med,2018,28(8):534-538.
[19] Occhetta E, Bortnik M, Vassanelli C. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry[J]. Europace ,2003,5:153-162.
[20] Occhetta E,Bortnik M,Audoglio R,et al. Inotropy controlled pacing in vasovagal syncope(INVASY):a multicentre randomized, single blind,controlled study[J]. Europace,2004,6:538-547.
[21] Kanjwal K,Karabin B,Kanjwal Y,et al. Preliminary observations on the use of closed-loop cardiac pacing in patients with refractory neurocardiogenic syncope[J]. J Interv Card Electrophysiol,2010,27:69-73.
[22] Palmisano P,Zaccaria M,Luzzi G,et al. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope:results of a long-term follow-up[J].Europace,2012,14:1038-1043.
[23] Russo V,Rago A,Papa AA,et al.The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope:a prospective, randomised, single-blind,crossover study[J]. Heart, 2013,99:1609-1613.
[24] Bortnik M,Occhetta E,Dell’Era G,et al. Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope[J]. J Cardiovasc Med,2012,13:242-245.
[25] Yu S,Kanjwal K,He W,et al. A long-term follow-up on the use of closed-loop cardiac pacing in patients with refractory neurocardiogenic syncope[J]. J Innovations Card Rhythm Manag,2015,6:1982-1985.
[26] Baron-Esquivias G,Morillo CA,Moya-Mitjans A,et al. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope:the SPAIN study[J]. J Am Coll Cardiol,2017,70:1720-1728.
[27] Griesbach L,Huber T,Knote B,et al. Closed loop stimulation:therapy for malignant neurocardiogenic syncope[J]. Prog Biomed Res,2002,7:242-247.